Full-Time

Head of Platform Biology

Confirmed live in the last 24 hours

Deep Genomics

Deep Genomics

51-200 employees

AI-driven drug discovery and development

AI & Machine Learning
Biotechnology

Expert

Cambridge, MA, USA

Position requires onsite presence in Cambridge, MA.

Category
Genomics
Biology Lab & Research
Biology & Biotech
Requirements
  • PhD in the biological sciences with 15+ years of experience in relevant roles (or equivalent) working in early-stage drug development focused on target validation and nucleic acid therapies.
  • 8+ years building, managing, and leading teams successfully to meet goals of the organization, partners, and patients.
  • Breadth of therapeutic area expertise, and exposure to multiple therapeutic modalities - ideally including gene editing and RNA-targeted therapies.
  • Well versed in target discovery via human genetics, with a focus on experimental validation of novel target hypotheses.
  • Proven ability to work independently and cross-functionally with highly skilled teams in a fast-paced, entrepreneurial, and technical environment.
  • Strong managerial qualities, including a strategic and scientifically oriented mindset, attention to detail, strong organizational skills, emotional intelligence, credibility, integrity, creativity, and a willingness to have ideas challenged by team members and to challenge them.
  • Ability to organize and communicate complex data sets in a clear and concise manner to key stakeholders from diverse backgrounds.
  • Prior experience working with or leading collaborations with external biotechnology, academic, and contract research organizations.
Responsibilities
  • Work with stakeholders across the organization to define and execute a strategy that grows the AI platform to unlock new genetic medicines.
  • Develop a biology-focused screening platform to support multiple AI platform goals.
  • Lead screening campaigns from target selection through hit finding and validation in preclinical animal models, leveraging the AI platform as appropriate.
  • Deliver proof of concept data for optimized molecules that demonstrate value of our AI-platform.
  • Evaluate, triage, and cross-validate targets discovered using Deep Genomics platform by orthogonal approaches including functional genomics, mechanistic biology, biochemistry, and disease models.
  • Contribute to key corporate initiatives to advance findings from the AI platform into clinical development through strategic partnering and business development activities.
  • Build an environment & culture focused on generating high-quality proprietary data.
  • Serve as the subject matter expert on cell biology & therapeutics development in setting strategy on initiatives to validate and expand the platform in close collaboration with the machine learning, Target ID, and Genomics teams.
  • Demonstrate strong leadership, accountability, interpersonal and mentorship skills.
  • Present in internal and external venues, and publish in peer-reviewed journals as appropriate.
Desired Qualifications
  • The current areas of focus are genetically defined targets in the liver and CNS, so familiarity with corresponding cell models, animal models, and delivery systems would be beneficial.
  • Hands-on experience developing and running industrialized NGS-based workflows is preferred.
  • Strong computational background or demonstrated ability to interface with computational biology teams to develop scalable analytical tools.
  • Experience with multi-site project management and team leadership.

Deep Genomics focuses on drug development in the biotechnology sector by utilizing artificial intelligence to explore RNA biology and discover potential therapies for genetic conditions. The main product is the AI Workbench, a tool that analyzes data to predict and identify new drug targets. This company distinguishes itself from competitors by its specific focus on RNA splicing and the continuous improvement of its AI Workbench, which has evolved through multiple versions to enhance its capabilities in targeting complex genetic diseases. The goal of Deep Genomics is to accelerate the drug discovery process and provide better treatment options for patients suffering from genetic disorders.

Company Stage

Series C

Total Funding

$230.3M

Headquarters

Toronto, Canada

Founded

2014

Growth & Insights
Headcount

6 month growth

1%

1 year growth

1%

2 year growth

-1%
Simplify Jobs

Simplify's Take

What believers are saying

  • AI integration with CRISPR allows precise gene editing and therapeutic development.
  • AI-driven platforms optimize clinical trial designs, reducing costs and time to market.
  • AI identifies novel biomarkers, expanding target discovery capabilities.

What critics are saying

  • Increased competition from companies like Insitro and Recursion Pharmaceuticals.
  • Rapid technological advancements may render current AI Workbench obsolete.
  • Ethical concerns and regulatory scrutiny could delay product development timelines.

What makes Deep Genomics unique

  • Deep Genomics uses AI to unravel RNA biology for drug development.
  • The AI Workbench identifies novel drug targets and therapeutic candidates.
  • BigRNA model advances RNA disease mechanism discovery and candidate therapeutics.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Company Equity

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

Professional Development Budget